Here are the 10-K annual reports from LENSAR, Inc. (LNSR) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-K covers the audited annual report, with the full financial statements, so if you follow LNSR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full LNSR filings page.
LENSAR, Inc. filed Amendment No. 1 to its annual report to add full Part III disclosures on directors, executive compensation, ownership, related-party transactions, and auditor fees. As of April 28, 2026, 12,104,328 shares of common stock were outstanding.
North Run Capital and affiliates beneficially own about 55% of LENSAR’s common stock and 45.1% combined voting power, following a $20.0 million 2024 private placement in Series A Convertible Preferred Stock and warrants. CEO Nicholas T. Curtis received $2,344,966 in total 2025 compensation; COO Alan B. Connaughton and CFO Thomas R. Staab earned $1,075,472 and $782,001, respectively.
LENSAR, Inc. is a commercial-stage medical device company focused on advanced laser systems for cataract surgery, led by its ALLY Robotic Cataract Laser System. The ALLY System combines imaging, treatment planning and dual-modality laser capabilities in a compact unit designed for use in an operating room or in-office suite.
The company targets growing global cataract volumes and low current use of lasers, emphasizing improved visual outcomes, especially for patients with astigmatism choosing premium, largely out-of-pocket procedures. LENSAR highlights proprietary AI-driven imaging, Refractive Capsulorhexis, wireless data integration and a sizable patent portfolio as key competitive strengths, while noting risks including termination of a prior merger agreement, ongoing operating losses, regulatory demands, supply-chain pressures and the need for additional capital and continued market adoption of the ALLY System.